Cargando…
Rare diseases and orphan drugs: 500 years ago
In 1581 Rembert Dodoens wrote “Medicinalium observationum exempla rara, recognita et aucta” a Latin book about the diagnosis and treatment of disorders with a low prevalence.
Autor principal: | Dooms, Marc M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687102/ https://www.ncbi.nlm.nih.gov/pubmed/26691530 http://dx.doi.org/10.1186/s13023-015-0353-3 |
Ejemplares similares
-
Orphan Drugs, Compounded Medication and Pharmaceutical Commons
por: Hendrickx, Kim, et al.
Publicado: (2021) -
Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2021) -
Orphan devices: yesterday is history; tomorrow is mystery: towards a European orphan device directive?
por: Dooms, Marc M
Publicado: (2016) -
Biomolecular Evidence of Silk from 8,500 Years Ago
por: Gong, Yuxuan, et al.
Publicado: (2016) -
Exome sequencing of 500 Brazilian patients with rare diseases: what we have learned
por: Quaio, Caio Robledo D’Angioli Costa, et al.
Publicado: (2022)